戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 poietic cells, to infer the lineage-specific haematopoietic activity present in human breast tumours.
2                                Mechanisms of haematopoietic and cardiac patterning remain poorly unde
3 P and Wnt signalling in the establishment of haematopoietic and cardiac progenitors during embryogene
4 s expressed in early mesoderm and marks both haematopoietic and cardiac progenitors.
5 e hemangiogenic cell lineage development.How haematopoietic and endothelial cell lineages are specifi
6 th Organization classification of tumours of haematopoietic and lymphoid tissues and the Internationa
7 sion of the WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues includes new criteri
8  conditional knockout of Wt1 in endothelial, haematopoietic and myeloid-derived suppressor cells is s
9       Inflammasomes are broadly expressed in haematopoietic and non-haematopoietic cells and can trig
10 lymphoid cells (ILCs) communicate with other haematopoietic and non-haematopoietic cells to regulate
11 hibits a liver bud-like phenotype, including haematopoietic and stromal cells as well as a neuronal n
12  Altogether, these findings demonstrate that haematopoietic ANGPTL4 deficiency increases atherogenesi
13 urthermore, hyperlipidemic mice deficient in haematopoietic ANGPTL4 have higher blood leukocyte count
14                                   In primary haematopoietic cell cultures, silencing of TRIB3 facilit
15                                       In the haematopoietic cell line UT7/mpl, silencing of TRIB3 inc
16 ble repopulating ability, but with different haematopoietic cell lineage outputs.
17                  Allelic variants of the pan-haematopoietic cell marker CD45, identified as CD45.1 an
18 .1 and CD45.2 donor cells, and characterised haematopoietic cell reconstitution in dual-expressing CD
19 Many of the factors affecting the success of haematopoietic cell transplantation are still unknown.
20                                         Each haematopoietic cell type had a distinct metabolic signat
21 of a diverse array of evolutionarily ancient haematopoietic cell types, including dendritic cells, mo
22 ic and homotypic motif-pairs with particular haematopoietic cell types.
23 d intake and fetal RA signalling acting in a haematopoietic cell-autonomous manner.
24 tivation molecule (SLAM) family of homotypic haematopoietic cell-specific receptors, we determined th
25                         PARP14 deficiency in haematopoietic cells accelerates the development and inf
26 ng phenotype of loss of most endothelial and haematopoietic cells and a significant increase in cardi
27 on are intertwined in bone marrow, therefore haematopoietic cells and bone cells could be extrinsic f
28  broadly expressed in haematopoietic and non-haematopoietic cells and can trigger numerous downstream
29 erminal differentiation and function of some haematopoietic cells are regulated by sex hormones, but
30 uring EHT results in increased production of haematopoietic cells due to loss of Sox17-mediated repre
31 ntification of the relevant role of ADRB1 in haematopoietic cells during acute injury and the protect
32         Transcriptional programmes active in haematopoietic cells enable a variety of functions inclu
33                                 We find that haematopoietic cells expressing mutant U2AF1(S34F), incl
34 been established as a marker system to track haematopoietic cells following congenic mouse bone marro
35                 Our data indicate that young haematopoietic cells have the capacity to rejuvenate bon
36 ot induce cell death in human melanocytes or haematopoietic cells in NSG mice.
37 tocols for the generation of endothelial and haematopoietic cells in vivo and in vitro.
38 ect is recapitulated by engraftment of young haematopoietic cells into old animals.
39                       The differentiation of haematopoietic cells is regulated by a plethora of so-ca
40 ls; the age-related increase of TNF-alpha in haematopoietic cells may perform as a negative factor in
41 -sensing' receptors GPR43 and GPR109A in non-haematopoietic cells mediate these protective effects.
42  paracrine effects of extrinsic factors from haematopoietic cells on human mesenchymal stem cells (MS
43 ted that there are paracrine interactions of haematopoietic cells on human MSCs; immunosenescence may
44  as a negative factor in the interactions of haematopoietic cells on MSCs via TNF-alpha receptors and
45                                 Vascular and haematopoietic cells organize into specialized tissues d
46 ents suggest that REGgamma's function in non-haematopoietic cells primarily contributes to the phenot
47                                         Most haematopoietic cells renew from adult haematopoietic ste
48 ene in foamy macrophages and it's absence in haematopoietic cells results in larger atherosclerotic p
49 uted with wild-type, Nek7(-/-) or Nlrp3(-/-) haematopoietic cells showed that NEK7 was required for N
50                         Our data showed that haematopoietic cells stimulate proliferation, osteoblast
51 with the adaptive immune system and with non-haematopoietic cells to promote immunity, inflammation a
52 ommunicate with other haematopoietic and non-haematopoietic cells to regulate immunity, inflammation
53 in HSCs in vivo was lower than in most other haematopoietic cells, even if we controlled for differen
54                         In contrast to other haematopoietic cells, ILC2s selectively express the NMU
55 P) is expressed by only 0.02% of bone marrow haematopoietic cells, including almost all HSCs.
56 eness to IFNgamma by myeloid cells and other haematopoietic cells, including T cells or fibroblasts,
57 pletion of neutrophils, ablation of Adrb1 in haematopoietic cells, or blockade of PSGL-1, the recepto
58 sues, 7 fetal tissues and 6 purified primary haematopoietic cells, resulted in identification of prot
59 t uses the transcriptomes of over 200 murine haematopoietic cells, to infer the lineage-specific haem
60  (ES) cells to both primitive and definitive haematopoietic cells.
61 sues including brain, heart, vasculature and haematopoietic cells.
62 throughout the vertebrates suggest a role in haematopoietic cells.
63 atients showed increased Notch signalling in haematopoietic cells.
64 which was not previously associated with non-haematopoietic cells.
65  system is supported by Ifnar1-deficient non-haematopoietic cells.
66 FRP-3 and sFRP-5 are dominantly expressed in haematopoietic cells; the age-related increase of TNF-al
67 g next-generation sequencing (NGS), observed haematopoietic clones in 10% of 70-year olds and rarely
68 ever, these studies could only detect common haematopoietic clones->0.02 variant allele fraction (VAF
69 ular niche monolayers to induce outgrowth of haematopoietic colonies containing cells with functional
70 apies requires identifying key regulators of haematopoietic commitment from human pluripotent stem ce
71  reduces reperfusion injury by targeting the haematopoietic compartment.
72  the brain requires Ifnar1 deficiency in the haematopoietic compartment.
73 table longitudinally and present in multiple haematopoietic compartments, suggesting a long-lived hae
74 II HSC/P traffic regulation and redefine the haematopoietic consequences of anti-angiotensin therapy
75                      Understanding how early haematopoietic development occurs is of fundamental impo
76 zebrafish to investigate the role of iqcg in haematopoietic development, and find that the numbers of
77 is Review, we discuss what is known of human haematopoietic development: the anatomical sites at whic
78 t are important for the establishment of the haematopoietic developmental program.
79  our study reveals a positive role for GO in haematopoietic differentiation and suggests that further
80 t stem cells and holds promise for modelling haematopoietic disease in humanized mice and for therape
81 signs or symptoms of mastocytosis or another haematopoietic disease, no BM investigation is required,
82 factors have been approved in the context of haematopoietic disorders, and mutations that affect chro
83       Producing these cells would accelerate haematopoietic drug toxicity testing and treatment of pa
84                                      The pro-haematopoietic effects of EETs were conserved in the dev
85  for their capacity to promote multi-lineage haematopoietic engraftment in mouse hosts.
86                    At BCL2L11, we identify a haematopoietic enhancer hub that is inactivated by the E
87 sis models, we show that genetic ablation of haematopoietic FAK does not affect primary tumour growth
88  of this master regulator of endothelial and haematopoietic fate enhances our understanding of early
89 ependent Wnt target, sufficient to establish haematopoietic fate in early mesoderm when BMP and Wnt c
90 se findings demonstrate that the endothelial haematopoietic fate switch is actively repressed in a po
91 GRS-transduced endothelial cells commit to a haematopoietic fate, yielding rEC-HSCs that no longer re
92  arterial identity function later to repress haematopoietic fate.
93  we do not know how distinct endothelial and haematopoietic fates are parsed during the transition.
94 narily conserved pathway regulating multiple haematopoietic generation and regeneration processes.
95  the TGFbeta signalling activation decreased haematopoietic genes expression and increased the transc
96                    Here we show that the key haematopoietic LIM-domain-binding protein-1 (LDB1) TF co
97 itical role during both myeloid and lymphoid haematopoietic lineage commitment.
98                    The mechanisms underlying haematopoietic lineage decisions remain disputed.
99              Using cellular model systems of haematopoietic lineage differentiation here we demonstra
100 ntation demonstrates that they have distinct haematopoietic lineage outputs.
101 doglin (Eng)-dependent manner in cardiac and haematopoietic lineage specification.
102 al programme and favour specification of the haematopoietic lineage.
103 for the development and survival of multiple haematopoietic lineages.
104  platelet counts, and contribute to multiple haematopoietic lineages.
105 he same disease, paving the way for treating haematopoietic malignancies with a new category of epige
106 ions in PRC2 components occur in a subset of haematopoietic malignancies, suggesting that this comple
107 e anlage, remodels into bone and organizes a haematopoietic microenvironment.
108                                              Haematopoietic multipotential progenitor cells, as well
109          NK cells mediate resistance against haematopoietic neoplasms but are generally considered to
110 rst HSCs and the signalling landscape of the haematopoietic niche.
111                              The ontogeny of haematopoietic niches in vertebrates is essentially unkn
112 ng and that plaque macrophages may not be of haematopoietic origin.
113 that derepression of these programs augments haematopoietic output.
114 et production and an organ with considerable haematopoietic potential.
115 cated, hyperactive ASXL1-BAP1 complexes in a haematopoietic precursor cell line results in global era
116                 The gradual reprogramming of haematopoietic precursors into the T-cell fate is charac
117 different cell types, including endothelial, haematopoietic progenitor and myeloid-derived suppressor
118  transgenic mice alters splicing and reverts haematopoietic progenitor cell expansion induced by muta
119 d that the egress population is comprised of haematopoietic progenitor cells (CD36(+)GPA(-/low)).
120                  Continuous thymic homing of haematopoietic progenitor cells (HPCs) via the blood is
121 sed proliferation of Lin(-) Sca-1(+) cKit(+) haematopoietic progenitor cells (LSKs) and common lympho
122 riven by the hormone thrombopoietin by which haematopoietic progenitor cells give rise to megakaryocy
123 usceptibility to leukaemic transformation of haematopoietic progenitor cells, and is preferentially r
124  that in primary cultures derived from human haematopoietic progenitor cells, thrombopoietin-induced
125                                              Haematopoietic progenitors and CD14+ monocytes are usual
126        Here we show that deletion of Brd1 in haematopoietic progenitors causes variegated expression
127                            Analysis of early haematopoietic progenitors from normal individuals revea
128 ature and immature megakaryocytes along with haematopoietic progenitors in the extravascular spaces o
129 c endothelium, which only produced primitive haematopoietic progenitors.
130 ematopoietic stem cells (HSCs) to restricted haematopoietic progenitors.
131 nary analysis further demonstrates that this haematopoietic programme is highly conserved between zeb
132 onal regulators capable of inducing distinct haematopoietic programs from hPSCs: pan-myeloid (ETV2 an
133 ation of NF-kappaB-inhibited BM ECs enhanced haematopoietic recovery and protected mice from pancytop
134 appaB promotes improved HSC function and pan-haematopoietic recovery.
135 ic TF ChIP-seq datasets, we demonstrate that haematopoietic-related motif-pairs commonly occur with h
136 rated that they are capable of multi-lineage haematopoietic repopulation of myeloablated adult mice s
137      The developmental stage of the block in haematopoietic specification is not known.
138 mogenic endothelial cells, a key step during haematopoietic specification.
139                 Small molecules that enhance haematopoietic stem and progenitor cell (HSPC) expansion
140 that regulate both leukocyte trafficking and haematopoietic stem and progenitor cell (HSPC) maintenan
141                                              Haematopoietic stem and progenitor cell (HSPC) transplan
142 steogenic progenitor CAR cells essential for haematopoietic stem and progenitor cell maintenance in v
143 oietic compartments, suggesting a long-lived haematopoietic stem and progenitor cell of origin.
144  model of MDS results in a rapid loss of MDS haematopoietic stem and progenitor cells (HSPCs) and rev
145                   Here we purify human CD34+ haematopoietic stem and progenitor cells (HSPCs) from di
146 ed lncRNA expression profiles from the CD34+ haematopoietic stem and progenitor cells (HSPCs) from pa
147 ble deletion of Foxc1 in adult mice depleted haematopoietic stem and progenitor cells and reduced CXC
148                                              Haematopoietic stem and progenitor cells are maintained
149                           MiR-193b-deficient haematopoietic stem and progenitor cells exhibit increas
150 actor-mediated cell fate conversion produces haematopoietic stem and progenitor cells from pluripoten
151                    Here we use primary mouse haematopoietic stem and progenitor cells immortalized wi
152 cient to convert haemogenic endothelium into haematopoietic stem and progenitor cells that engraft my
153 n enrichment model to purify a population of haematopoietic stem and progenitor cells with more than
154 nd maintenance of the mesenchymal niches for haematopoietic stem and progenitor cells.
155 in complex that protects telomeres, improves haematopoietic stem cell (HSC) activity during aging.
156                                In the blood, haematopoietic stem cell (HSC) ageing is linked to sever
157                                              Haematopoietic stem cell (HSC) gene therapy has demonstr
158 orta-gonad-mesonephros (AGM) region prior to haematopoietic stem cell (HSC) generation.
159          Integrins play an important role in haematopoietic stem cell (HSC) maintenance in the bone m
160 mmalian stem cells and their niches, but the haematopoietic stem cell (HSC) niche remains incompletel
161 le, only p18 and p27 can negatively regulate haematopoietic stem cell (HSC) self-renewal.
162 lt haematopoiesis is the outcome of distinct haematopoietic stem cell (HSC) subtypes with self-renewa
163 e, but whether they affect haematopoiesis or haematopoietic stem cell (HSC)-mediated reconstitution a
164 ipotent stem cell technologies for modelling haematopoietic stem cell development and blood therapies
165 antifibrotic agent and negative regulator of haematopoietic stem cell differentiation which is proces
166 otrophic factor partners are produced in the haematopoietic stem cell environment.
167 a composition associated with less efficient haematopoietic stem cell function.
168        However, the mechanisms that regulate haematopoietic stem cell homeostasis and function remain
169 in is a potent oncogene playing key roles in haematopoietic stem cell homeostasis and malignant haema
170     Yet the expression of BRAF(V600E) in the haematopoietic stem cell lineage causes leukaemic and tu
171 otrophic factors are novel components of the haematopoietic stem cell microenvironment, revealing tha
172 ) cells, CD8(+) T cell memory precursors and haematopoietic stem cell progenitors, but that was disti
173  niche and function coordinately to regulate haematopoietic stem cell self-renewal and mobilization.
174          While Asxl2 was required for normal haematopoietic stem cell self-renewal, Asxl2 loss promot
175 drenoleukodystrophy (X-ALD) before and after haematopoietic stem cell transplantation (HSCT) and to e
176 omising source of stem cells to use in early haematopoietic stem cell transplantation (HSCT) approach
177 ese findings may have relevance for clinical haematopoietic stem cell transplantation and mobilizatio
178 l encephalomyopathy who underwent allogeneic haematopoietic stem cell transplantation between 2005 an
179                                   Allogeneic haematopoietic stem cell transplantation can restore thy
180 g, early progression halted after allogeneic haematopoietic stem cell transplantation from a related
181 ge 25 years (range 10-41 years) treated with haematopoietic stem cell transplantation from related (n
182                                   Allogeneic haematopoietic stem cell transplantation has been demons
183                                              Haematopoietic stem cell transplantation has been propos
184 long-term neurological benefit of allogeneic haematopoietic stem cell transplantation in adult cerebr
185 pathy with axonal spheroids and suggest that haematopoietic stem cell transplantation might have a th
186 adrenoleukodystrophy treated with allogeneic haematopoietic stem cell transplantation on a compassion
187                                   Allogeneic haematopoietic stem cell transplantation should be consi
188 luding immunoablation followed by autologous haematopoietic stem cell transplantation, mesenchymal an
189 blished as causing limbic encephalitis after haematopoietic stem cell transplantation, particularly a
190  displayed chimerism in CSF1R acquired after haematopoietic stem cell transplantation.
191 r eliminating latently infected cells before haematopoietic stem cell transplantation.
192 normalize within 1 year after treatment with haematopoietic stem cell transplantation.
193                            Here, using human haematopoietic stem cell-engrafted NSG-HLA-DQ8 transgeni
194 tes that manifested concurrent expression of haematopoietic stem cell/progenitor and myeloid progenit
195 astable intermediates that had collapsed the haematopoietic stem cell/progenitor gene expression prog
196 Repeated cell divisions induce DNA damage in haematopoietic stem cells (HSC) and telomeres are sensit
197            Microenvironment cues received by haematopoietic stem cells (HSC) are important in regulat
198  metabolic differences between murine normal haematopoietic stem cells (HSCs) and CML stem cells usin
199 have an increased bone marrow (BM) long-term haematopoietic stem cells (HSCs) and granulocyte-macroph
200 aemia (AML) to demonstrate that transforming haematopoietic stem cells (HSCs) and multipotent progeni
201                                              Haematopoietic stem cells (HSCs) are arguably the most e
202                 Umbilical cord blood-derived haematopoietic stem cells (HSCs) are essential for many
203                                              Haematopoietic stem cells (HSCs) are responsible for the
204 oiesis, including regulating self-renewal of haematopoietic stem cells (HSCs) as well as myeloid and
205                 In mice, deletion of PTEN in haematopoietic stem cells (HSCs) causes perturbed haemat
206 ls in 5q-MDS patients, it is unclear whether haematopoietic stem cells (HSCs) could also be the initi
207                                              Haematopoietic stem cells (HSCs) derive from haemogenic
208                                              Haematopoietic stem cells (HSCs) emerge during embryogen
209          During embryonic development, adult haematopoietic stem cells (HSCs) emerge preferentially i
210 hat generates the first adult populations of haematopoietic stem cells (HSCs) from hemogenic endothel
211             Haematopoietic stresses mobilize haematopoietic stem cells (HSCs) from the bone marrow to
212                                         Aged haematopoietic stem cells (HSCs) generate more myeloid c
213 r, its application to long-term repopulating haematopoietic stem cells (HSCs) has remained elusive.
214 thway yielded high levels of gene editing in haematopoietic stem cells (HSCs) in a mouse model of hum
215           One day prior to mass emergence of haematopoietic stem cells (HSCs) in the foetal liver at
216                                              Haematopoietic stem cells (HSCs) require the right compo
217                                              Haematopoietic stem cells (HSCs) reside in a perivascula
218                                              Haematopoietic stem cells (HSCs) reside in distinct nich
219                                              Haematopoietic stem cells (HSCs) self-renew for life, th
220 sleep deprivation reduces the ability of its haematopoietic stem cells (HSCs) to engraft and reconsti
221 tly from tissues and use it to compare mouse haematopoietic stem cells (HSCs) to restricted haematopo
222   Most haematopoietic cells renew from adult haematopoietic stem cells (HSCs), however, macrophages i
223                                              Haematopoietic stem cells (HSCs), which sustain producti
224  MPN through profound detrimental effects on haematopoietic stem cells (HSCs).
225 programming adult mouse endothelial cells to haematopoietic stem cells (rEC-HSCs) through transient e
226 ic stem-cell self-renewal, expanding splenic haematopoietic stem cells and erythropoiesis during preg
227 ic development, and find that the numbers of haematopoietic stem cells and multilineage-differentiate
228 c stem cell microenvironment, revealing that haematopoietic stem cells and neurons are regulated by s
229 f vascular origin have increased circulating haematopoietic stem cells and progenitors (HSC/P).
230 ine a CRISPR-based methodology for targeting haematopoietic stem cells by homologous recombination at
231             This process relies on quiescent haematopoietic stem cells capable of differentiating, se
232       Here we show that loss of autophagy in haematopoietic stem cells causes accumulation of mitocho
233  cells into autologous authentic engraftable haematopoietic stem cells could aid treatment of haemato
234     However, approximately one-third of aged haematopoietic stem cells exhibit high autophagy levels
235                                 We find that haematopoietic stem cells express RET and that its neuro
236                                              Haematopoietic stem cells expressed high levels of oestr
237   Ex vivo gene correction in patient-derived haematopoietic stem cells followed by autologous transpl
238 d 588-A successfully isolates ALDH(hi) human haematopoietic stem cells from heterogeneous cord blood
239 nd longevity, and is critical for protecting haematopoietic stem cells from metabolic stress.
240 ss permeable arterial blood vessels maintain haematopoietic stem cells in a low reactive oxygen speci
241                             Strikingly, most haematopoietic stem cells in aged mice share these alter
242 e candidate cells that constitute niches for haematopoietic stem cells in the marrow, including osteo
243                                    With age, haematopoietic stem cells lose their ability to regenera
244 leeting transition of endothelial cells into haematopoietic stem cells remain undefined.
245                        We analyse individual haematopoietic stem cells throughout differentiation int
246 f-renewal capacity similar to those of adult haematopoietic stem cells, and can be used for clonal en
247 while tracking its development (pre-leukemic haematopoietic stem cells, leukemic stem cells [LSCs], a
248              Here, to yield functional human haematopoietic stem cells, we perform morphogen-directed
249  homologous recombination at the HBB gene in haematopoietic stem cells.
250 nvironments necessary for the maintenance of haematopoietic stem cells.
251  the action of a small number of multipotent haematopoietic stem cells.
252 eneration potential similar to healthy young haematopoietic stem cells.
253 to preserve the regenerative capacity of old haematopoietic stem cells.
254 hro-myeloid progenitors (EMPs) distinct from haematopoietic stem cells.
255  ANX-A1-deficiency exaggerates inflammation, haematopoietic stem progenitor cell (HSPC) activity and
256 ne produced mainly in the ovaries, increased haematopoietic stem-cell division in males and females.
257 evels increased during pregnancy, increasing haematopoietic stem-cell division, haematopoietic stem-c
258 ncreasing haematopoietic stem-cell division, haematopoietic stem-cell frequency, cellularity, and ery
259 tic cells are regulated by sex hormones, but haematopoietic stem-cell function is thought to be simil
260 monstrate that autophagy actively suppresses haematopoietic stem-cell metabolism by clearing active,
261 7/G-CSF axis, and rhythmic modulation of the haematopoietic stem-cell niche.
262  termination cytokines that normally restore haematopoietic stem-cell quiescence.
263 hrough epigenetic deregulations, and impairs haematopoietic stem-cell self-renewal activity and regen
264        Oestrogen/ERalpha signalling promotes haematopoietic stem-cell self-renewal, expanding splenic
265 ed no benefit of mobilisation and autologous haematopoietic stem-cell transplantation (HSCT) compared
266 ight who had previously undergone allogeneic haematopoietic stem-cell transplantation) were enrolled
267 helium followed by screening of 26 candidate haematopoietic stem-cell-specifying transcription factor
268 ssue (CHT), the first niche where definitive haematopoietic stem/progenitor cells (HSPCs) home in zeb
269 tally validated regulatory network model for haematopoietic stem/progenitor cells (HSPCs).
270 tify expression of BCL6 in a subset of human haematopoietic stem/progenitor cells (HSPCs).
271  and a new Msi2 reporter model, we show that haematopoietic stem/progenitor cells display preferentia
272 eat deal about the phenotype and function of haematopoietic stem/progenitor cells, a major challenge
273  profiling shows aberrant differentiation of haematopoietic stem/progenitor cells, impaired erythroid
274 hus, Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells, suggesting a novel
275  all three progenitor populations as well as haematopoietic stem/progenitor cells.
276                                              Haematopoietic stresses mobilize haematopoietic stem cel
277 ry for the physiological response to diverse haematopoietic stresses.
278  zebrafish niches, as well as with mammalian haematopoietic-supportive cells to further the understan
279 with other temporally and spatially distinct haematopoietic-supportive zebrafish niches, as well as w
280                        Pcid2 deletion in the haematopoietic system causes skewed lymphoid lineage spe
281  this method, we explore the dynamics of the haematopoietic system from a demand control system persp
282 ng ageing and the accelerated failure of the haematopoietic system in Fanconi anaemia patients.
283                        Itgav deletion in the haematopoietic system leads to a similar PB phenotype an
284 presents the embryonic rudiment of the adult haematopoietic system, remains uncertain.
285 r pathway, led to a complete collapse of the haematopoietic system, which phenocopied the highly pene
286 n other rapidly renewing tissues such as the haematopoietic system.
287 ing embryogenesis and give rise to the adult haematopoietic system.
288          Utilizing a compendium of 289 mouse haematopoietic TF ChIP-seq datasets, we demonstrate that
289 we show that the stromal cells of the caudal haematopoietic tissue (CHT), the first niche where defin
290 tal1, the earliest expressed endothelial and haematopoietic transcription factor genes identified to
291 t mice, we study the function of Tal1, a key haematopoietic transcription factor, and demonstrate, co
292  due to loss of Sox17-mediated repression of haematopoietic transcription factors (Runx1 and Gata2).
293                           The endothelial to haematopoietic transition (EHT) is a key developmental p
294 nd identity are essential for endothelial-to-haematopoietic transition (EHT), an embryonic process th
295 hanisms governing this unique endothelial to haematopoietic transition remain unclear.
296 source for paediatric and adults requiring a haematopoietic transplant, particularly for patients of
297 eceptors, we determined that phagocytosis of haematopoietic tumour cells during SIRPalpha-CD47 blocka
298 s are much more efficient at phagocytosis of haematopoietic tumour cells, compared with non-haematopo
299 ematopoietic tumour cells, compared with non-haematopoietic tumour cells, in response to SIRPalpha-CD
300 nism by which macrophages engulf and destroy haematopoietic tumour cells.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top